These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2165081)

  • 1. Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design.
    Ebert SC; Craig WA
    Infect Control Hosp Epidemiol; 1990 Jun; 11(6):319-26. PubMed ID: 2165081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of pharmacokinetic and pharmacodynamic parameters fro establishing the optimal dosage of antibacterials].
    Gomis Gavilán M; Prieto Prieto J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):104-12. PubMed ID: 7711116
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibiotics and overweight].
    Madsen H; Brøsen K; Frimodt-Møller N; Gahrn-Hansen B
    Ugeskr Laeger; 2005 May; 167(21):2266-70. PubMed ID: 15962851
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of pharmacokinetics and pharmacodynamics for effective treatment of infections.
    Mattie H
    Clin Investig; 1993 Jun; 71(6):480-2. PubMed ID: 8394759
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetic effects of antibiotics on the development of bacterial resistance particularly in reference to azithromycin].
    Wenisch C
    Wien Med Wochenschr; 2000; 150(3):37-41. PubMed ID: 10756595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dosage schedule of antibiotics on the treatment of serious infections.
    Bakker-Woudenberg IA; Roosendaal R
    Intensive Care Med; 1990; 16 Suppl 3():S229-34. PubMed ID: 2289996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confounding issues in estimation of patient-specific pharmacokinetic parameters and dosage individualization of aminoglycosides.
    Mehvar R
    Curr Clin Pharmacol; 2012 Feb; 7(1):28-35. PubMed ID: 22299767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Theoretical research for therapy of infection].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Aug; 43(8):815-23. PubMed ID: 1655924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in antibiotic measurement.
    Dasgupta A
    Adv Clin Chem; 2012; 56():75-104. PubMed ID: 22397029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of aminoglycosides in the intensive care unit.
    Radigan EA; Gilchrist NA; Miller MA
    J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of antibiotics in burn patients].
    Lesne-Hulin A; Bourget P; Carsin H
    Therapie; 1995; 50(6):575-86. PubMed ID: 8745959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections].
    Mazzei T; Novelli A; Arrigucci S
    Infez Med; 2009 Sep; 17 Suppl 4():37-57. PubMed ID: 20428019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial chemotherapy--its clinico-pharmacologic significance].
    Graber H
    Orv Hetil; 1989 Dec; 130(50):2671-5. PubMed ID: 2557571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What preclinical data are needed to justify once-daily therapy?
    Bergeron MG
    J Clin Pharmacol; 1992 Aug; 32(8):698-705. PubMed ID: 1487558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aminoglycoside antibiotics].
    Kubo H; Shinozaki K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():427-31. PubMed ID: 15658355
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of aminoglycosides in the newborn.
    van den Anker JN; Allegaert K
    Curr Pharm Des; 2012; 18(21):3114-8. PubMed ID: 22564303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracellular pharmacokinetics and pharmacodynamics of antibiotics].
    Tulkens PM
    Rev Pneumol Clin; 1996; 52 Suppl 2():S51-5. PubMed ID: 9033918
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.